Back
Ono Pharmaceutical Co., Ltd. 10K Form
Buy
58
OPHLY
Ono Pharmaceutical Co., Ltd.
Last Price:
$4.68
Seasonality Move:
4.03%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive OPHLY News And Ratings
See the #1 stock for the next 7 days that we like better than OPHLY
OPHLY Financial Statistics
Sales & Book Value
| Annual Sales: | $3.2B |
|---|---|
| Cash Flow: | $340.4M |
| Price / Cash Flow: | 12.54 |
| Annual Sales: | $3.87 |
| Price / Book: | 1.18 |
Profitability
| EPS (TTM): | 0.23360 |
|---|---|
| Net Income (TTM): | $329.5M |
| Gross Margin: | $2.2B |
| Return on Equity: | 6.13% |
| Return on Assets: | 4.63% |
Ono Pharmaceutical Co., Ltd. Earnings Forecast
Key Ono Pharmaceutical Co., Ltd. Financial Ratios
-
The Gross Profit Margin over the past 35 years for OPHLY is 68.90%.
-
The Selling, General & Administrative Expenses for OPHLY have been equal to 25.81% of Gross Profit Margin.
-
The Research & Development expenses have been 30.78% of Revenue.
-
The Interest Expense is 3.26% of Operating Income.
-
The Net Earning history of OPHLY is 10.30% of Total Revenues.
-
Per Share Earnings over the last 35 years have been positive in 22 years.
Ono Pharmaceutical Co., Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | OPHLY |
| Website: | ono-pharma.com/ja |
Debt
| Debt-to-Equity Ratio: | 0.16 |
|---|---|
| Current Ratio: | 2.99 |
| Quick Ratio: | 2.29 |
Price-to-Earnings
| Trailing P/E Ratio: | 19.73 |
|---|---|
| Forward P/E Ratio: | 0 |
OPHLY Technical Analysis vs Fundamental Analysis
Buy
58
Ono Pharmaceutical Co., Ltd. (OPHLY)
is a Buy
Is Ono Pharmaceutical Co., Ltd. a Buy or a Sell?
-
Ono Pharmaceutical Co., Ltd. stock is rated a BuyThe current Ono Pharmaceutical Co., Ltd. [OPHLY] share price is $4.59. The Score for OPHLY is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.